t(2;19)(p23;p13) TPM4/ALK
2013-01-01 Jean-Loup Huret   Affiliation1.Genetics, Dept Medical Information, University of Poitiers, CHU Poitiers Hospital, F-86021 Poitiers, France
Clinics and Pathology
Disease
Clinics
Only one case to date, an 18-month-old boy with a null-ALCL (Meech et al., 2001).
Cytology
Cells expressed both myeloid (CD13, CD33, HLA-DR) and natural killer (CD3-/CD56+, germline TCR genes, CD25+/CD122+/granzyme B+) cell antigens.
Evolution
The patient was in remission 14 months after completion of therapy.
Genes Involved and Proteins
Gene name
ALK (anaplastic lymphoma receptor tyrosine kinase)
Location
2p23.2
Protein description
1620 amino acids; ALK is a membrane associated tyrosine kinase receptor of the insulin receptor superfamily.
Gene name
TPM4 (tropomyosin)
Location
19p13.12
Protein description
248 amino acids; tropomyosins are actin-binding proteins; component of cytoskeletal microfilaments; role in the calcium dependent regulation of striated muscle.
Result of the Chromosomal Anomaly
Description
5TPM4-3ALK. Fusion between TPM4 nucleotide 714 and ALK nucleotide 4084.
Highly cited references
| Pubmed ID | Year | Title | Citations |
|---|---|---|---|
| 17131471 | 2006 | Identification of squamous cell carcinoma associated proteins by proteomics and loss of beta tropomyosin expression in esophageal cancer. | 57 |
| 40070162 | 2025 | Cutaneous Hemangioma With Epithelioid Features Harboring TPM3/4::ALK Fusions : A Distinct Entity or a Molecular Variant of Epithelioid Hemangioma? | 49 |
| 10934142 | 2000 | TPM3-ALK and TPM4-ALK oncogenes in inflammatory myofibroblastic tumors. | 40 |
| 25300797 | 2014 | Recurrent LRP1-SNRNP25 and KCNMB4-CCND3 fusion genes promote tumor cell motility in human osteosarcoma. | 32 |
| 38711893 | 2024 | Partial response to crizotinib + regorafenib + PD-1 inhibitor in a metastatic BRAF V600EMT colon cancer patient with acquired C-MET amplification and TPM4-ALK fusion: a case report. | 29 |
| 31278140 | 2019 | The effects of crizotinib in a transgenic Drosophila model expressing the human TPM4-ALK fusion gene or TPM4. | 28 |
| 40386559 | 2025 | Case Report: Clinical response of ensartinib for inflammatory myofibroblastic tumor of the urinary bladder with multiple metastases and TPM4-ALK fusion. | 27 |
| 29268561 | 2017 | Pulmonary inflammatory myofibroblastic tumor with TPM4-ALK translocation. | 11 |
| 35172497 | 2017 | Crizotinib Failure in a TPM4-ALK-Rearranged Inflammatory Myofibroblastic Tumor With an Emerging ALK Kinase Domain Mutation. | 0 |
| 41913317 | 2026 | TPM4::ALK Rearranged Cutaneous Epithelioid Vascular Tumor: A Case Report. | 0 |
| 42173697 | 2026 | Cutaneous Hemangioma With Epithelioid Features Harboring a TPM4::ALK Fusion. | 0 |
| 15764578 | 2004 | Low-grade sarcomas with CD34-positive fibroblasts and low-grade myofibroblastic sarcomas. | 0 |
| 12787312 | 2003 | Inflammatory myofibroblastic tumor with predominant anaplastic lymphoma kinase-positive cells lacking a myofibroblastic phenotype. | 0 |
| 17318615 | 2007 | Proteomic profiling of proteins dysregulted in Chinese esophageal squamous cell carcinoma. | 0 |
| 20092987 | 2010 | Effects of triterpenes from Ganoderma lucidum on protein expression profile of HeLa cells. | 0 |
| 17694547 | 2008 | Development of anaplastic lymphoma kinase (ALK) small-molecule inhibitors for cancer therapy. | 0 |
| 38266918 | 2024 | Molecular Screening in Anaplastic Lymphoma Kinase-Positive Anaplastic Large Cell Lymphoma: Anaplastic Lymphoma Kinase Analysis, Next-Generation Sequencing Fusion Gene Detection, and T-Cell Receptor Immunoprofiling. | 0 |
| 16984614 | 2006 | Absence of human herpesvirus-8 and Epstein-Barr virus in inflammatory myofibroblastic tumor with anaplastic large cell lymphoma kinase fusion gene. | 0 |
| 32868646 | 2020 | Lorlatinib for the treatment of inflammatory myofibroblastic tumour with TPM4-ALK fusion following failure of entrectinib. | 0 |
| 15080301 | 2004 | Assessment of t(2;5)(p23;q35) translocation and variants in pediatric ALK+ anaplastic large cell lymphoma. | 0 |
Article Bibliography
| Pubmed ID | Last Year | Title | Authors |
|---|---|---|---|
| 10934142 | 2000 | TPM3-ALK and TPM4-ALK oncogenes in inflammatory myofibroblastic tumors. | Lawrence B et al |
| 11493472 | 2001 | Unusual childhood extramedullary hematologic malignancy with natural killer cell properties that contains tropomyosin 4--anaplastic lymphoma kinase gene fusion. | Meech SJ et al |
| 16213362 | 2005 | Detection of ETV6 and RUNX1 gene rearrangements using fluorescence in situ hybridization in Mexican patients with acute lymphoblastic leukemia: experience at a single institution. | Pérez-Vera P et al |
Summary
Fusion gene
TPM4/ALK TPM4 (19p13.12) ALK (2p23.2) COF 441 442|TPM4/ALK TPM4 (19p13.12) ALK (2p23.2) M t(2;19)(p23;p13)|TPM4/ALK TPM4 (19p13.12) ALK (2p23.2) TIC
Citation
Jean-Loup Huret
t(2;19)(p23;p13) TPM4/ALK
Atlas Genet Cytogenet Oncol Haematol. 2013-01-01
Online version: http://atlasgeneticsoncology.org/haematological/1549/t(2
